Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help
Arta M. Monjazeb, Julia K. Tietze, Steven K. Grossenbacher, Hui Hua Hsiao, Anthony E. Zamora, Annie Mirsoian, Brent Koehn, Bruce R. Blazar, Jonathan M. Weiss, Robert H. Wiltrout, Gail D. Sckisel, William J. Murphy
Dive into the research topics of 'Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help'. Together they form a unique fingerprint.